Newcastle Disease Virus Archive - Seite 32 von 33 - IOZK

Newcastle disease virus (NDV): brief history of its oncolytic strains

2000-02-01/in International Publications, Newcastle Disease Virus /von 2000-02-01 / J. Clin. Virol. 2000 Feb;16(1):1-15

Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma

1999-05-05/in Glioblastoma, International Publications, Newcastle Disease Virus /von 1999-05-05 / JAMA 1999 May;281(17):1588-9

Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures

1999-02-01/in International Publications, Newcastle Disease Virus /von 1999-02-01 / Int. J. Oncol. 1999 Feb;14(2):205-15

Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

1999-01-01/in International Publications, Newcastle Disease Virus /von 1999-01-01 / Gene Ther. 1999 Jan;6(1):63-73

A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire

1998-12-01/in International Publications, Malignant Melanoma, Newcastle Disease Virus /von 1998-12-01 / Mol. Med. 1998 Dec;4(12):783-94

Introduction of adhesive and costimulatory immune functions into tumor cells by infection with Newcastle Disease Virus

1998-12-01/in International Publications, Newcastle Disease Virus /von 1998-12-01 / Int. J. Oncol. 1998 Dec;13(6):1105-15

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer

1997-04-01/in Breast Cancer, International Publications, Newcastle Disease Virus, Ovarian Cancer /von 1997-04-01 / J. Clin. Oncol. 1997 Apr;15(4):1354-66

Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy

1994-12-01/in International Publications, Newcastle Disease Virus, Soft Tissue Sarcoma /von 1994-12-01 / Cancer Res. 1994 Dec;54(23):6017-21

A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate

1992-01-01/in International Publications, Newcastle Disease Virus /von 1992-01-01 / Med Oncol Tumor Pharmacother 1992;9(4):169-71

A critical look at the subluxation hypothesis

1989-04-01/in International Publications, Newcastle Disease Virus /von 1989-04-01 / J Manipulative Physiol Ther 1989 Apr;12(2):152-5